TY - JOUR
T1 - Foxp3 expressing CD4+CD25high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells
AU - Viguier, Manuelle
AU - Lemaître, Fabrice
AU - Verola, Olivier
AU - Cho, Min Sun
AU - Gorochov, Guy
AU - Dubertret, Louis
AU - Bachelez, Hervé
AU - Kourilsky, Philippe
AU - Ferradini, Laurent
PY - 2004/7/15
Y1 - 2004/7/15
N2 - Dominant tolerance is mediated by regulatory T cells (Treg) that control harmful autoimmune T cells àn in the periphery. In this study, we investigate the implication of Treg in modulating infiltrating T lymphocytes in human metastatic melanoma. We found that CD4+CD25 high T cells are overrepresented in metastatic lymph nodes (LNs) with a 2-fold increased frequency compared with both tumor-free LNs and autologous PBMCs. These cells express the Foxp3 transcription factor, display an activated phenotype, and display a polyclonal TCR Vβ chain repertoire. They inhibit in vitro the proliferation and cytokine production of infiltrating CD4 +CD25- and CD8+ T cells (IL-2, IFN-γ) through a cell-contact-dependent mechanism, thus behaving as Treg. In some cases, the presence of Treg type 1/Th3-like lymphocytes could also be demonstrated. Thus, Treg are a major component of the immunosuppressive microenvironment of metastatic melanoma LNs. This could explain the poor clinical response of cancer patients under immunotherapeutic protocols, and provides a new basis for future immunotherapeutic strategies counteracting in vivo Treg to reinforce local antitumor immune responses.
AB - Dominant tolerance is mediated by regulatory T cells (Treg) that control harmful autoimmune T cells àn in the periphery. In this study, we investigate the implication of Treg in modulating infiltrating T lymphocytes in human metastatic melanoma. We found that CD4+CD25 high T cells are overrepresented in metastatic lymph nodes (LNs) with a 2-fold increased frequency compared with both tumor-free LNs and autologous PBMCs. These cells express the Foxp3 transcription factor, display an activated phenotype, and display a polyclonal TCR Vβ chain repertoire. They inhibit in vitro the proliferation and cytokine production of infiltrating CD4 +CD25- and CD8+ T cells (IL-2, IFN-γ) through a cell-contact-dependent mechanism, thus behaving as Treg. In some cases, the presence of Treg type 1/Th3-like lymphocytes could also be demonstrated. Thus, Treg are a major component of the immunosuppressive microenvironment of metastatic melanoma LNs. This could explain the poor clinical response of cancer patients under immunotherapeutic protocols, and provides a new basis for future immunotherapeutic strategies counteracting in vivo Treg to reinforce local antitumor immune responses.
UR - http://www.scopus.com/inward/record.url?scp=3142737258&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.173.2.1444
DO - 10.4049/jimmunol.173.2.1444
M3 - Article
C2 - 15240741
AN - SCOPUS:3142737258
SN - 0022-1767
VL - 173
SP - 1444
EP - 1453
JO - Journal of Immunology
JF - Journal of Immunology
IS - 2
ER -